Underdosed and Underappreciated: Why Japanese Community-Acquired Pneumonia Outcomes With Ampicillin-Sulbactam May Not Translate Globally

This publication has 9 references indexed in Scilit:

• Effectiveness of Ampicillin-Sulbactam Versus Ceftriaxone for the Initial Treatment of Community-Acquired Pneumonia in Older Adults: A Target Trial Emulation Study
  Open Forum Infectious Diseases, 2025
• Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including Acinetobacter baumannii
  Antibiotics, 2023
• Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016
  Microbiology Spectrum, 2022
• Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan
  BMC Infectious Diseases, 2021
• Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single‐center retrospective observational study
  Pharmacology Research & Perspectives, 2021
• Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of japanese society of chemotherapy, the japanese association for infectious diseases, and the japanese society for clinical microbiology in 2016: General view of the pathogens’ antibacterial susceptibility
  Journal of Infection and Chemotherapy, 2020
• Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
  American Journal of Respiratory and Critical Care Medicine, 2019
• Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: A multicenter, open-label, uncontrolled study
  Journal of Infection and Chemotherapy, 2015
• Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospital
  Journal of Antimicrobial Chemotherapy, 2005